 |  |
Discover the latest from 4HF Biotec at the AACR Annual meeting in San Diego. 4HF will present two exciting posters showcasing its newest advancements in the bioinformatic identification of targets and how its in silico tools can work in tandem with experimental data to gather insights about drug conjugates:
4HF will present the 4HF CancerDataMiner™ platform, accelerating target discovery and evaluation. Our presentation will delve into past, present, and future targets for drug conjugate development.
Title: 4HF CancerDataMiner platform accelerates target discovery and evaluation
Session Category: New Targets, Technologies, and Drug Delivery Systems
Session Date and Time: April 9, 2024, 9:00 AM – 12:30 PM Section 28
Location: Section 28
Poster Board Number: 9
Published Abstract Number: 4689
In collaboration with Reaction Biology, we’re thrilled to present a poster showcasing the ProLiFiler™ and the 4HF CancerDataMiner™ for preclinical profiling of drug conjugates, featuring extensive analysis of Kadcyla and Enhertu antitumor profiles in vitro.
Title: Potency and selectivity of ERBB2-targeting antibody drug conjugates in vitro
Session Category: Experimental and Molecular Therapeutics
Session Date and Time: Tuesday Apr 9, 2024 9:00 AM – 12:30 PM
Location: Poster Section 29
Poster Board Number: 1
Published Abstract Number: 4708